F Hausmann1, V V Iversen1, M Kristoffersen1, H Gundersen1, E Johannsson2,3, M Vika4,5. 1. Faculty of Education, Arts and Sports, Department of Sport, Food and Natural Sciences, Western Norway University of Applied Sciences, Bergen, Norway. 2. Faculty of Education, Arts and Sports, Department of Sport, Food and Natural Sciences, Western Norway University of Applied Sciences, Bergen, Norway. Erlingur.johannsson@hvl.no. 3. Center of Sport and Health Sciences, University of Iceland, Reykjavik, Iceland. Erlingur.johannsson@hvl.no. 4. Haukeland University Hospital, Bergen, Norway. 5. University of Bergen, Bergen, Norway.
Abstract
PURPOSE: The purpose of this study was to evaluate the effects of 16 weeks combined aerobic and resistance training, twice a week, on the physical performance in women treated for gynecological cancer. METHODS:Sixty women (56.9 ± 13.3 years) who had completed curative treatment for gynecological cancer were divided into two groups: a physical training group (PT) (n = 29) or a control group (C) (n = 31). The PT group performed two sessions of combined aerobic and resistance training weekly for 16 weeks. Peak oxygen consumption (V̇O2peak) and one repetition maximum (1RM) of leg press, leg extension, and chest press were measured before group assignment, after 16 weeks and at the 1-year follow-up. RESULTS: A significant increase in V̇O2peak (mlmin-1 kg-1) (29.7 ± 8.0 vs. 31.3 ± 8.3, p = .009), leg press (kg) (113.0 ± 27.3 vs. 116.7 ± 29.2, p = .047), leg extension (kg) (44.2 ± 10.1 vs. 48.0 ± 10.6, p < .001), and chest press (kg) (24.5 ± 7.5 vs. 26.9 ± 8.2, p = .001) was seen in the PT group from pre- to post-measurement. The PT group maintained the improved aerobic condition and muscle strength 1 year after the training intervention. In the C group, there were no significant differences between pre- and post-measurements, but a significant decrease (28.2 ± 7.5 vs. 27.0 ± 7.3, p = .040) in the V̇O2peak from post to 1-year follow-up measurements. CONCLUSIONS:Combined aerobic and resistance training twice a week in 16 weeks improves V̇O2peak and maximal strength in women treated for gynecological cancer. The training effects were sustained after 1 year in the PT group.
RCT Entities:
PURPOSE: The purpose of this study was to evaluate the effects of 16 weeks combined aerobic and resistance training, twice a week, on the physical performance in women treated for gynecological cancer. METHODS: Sixty women (56.9 ± 13.3 years) who had completed curative treatment for gynecological cancer were divided into two groups: a physical training group (PT) (n = 29) or a control group (C) (n = 31). The PT group performed two sessions of combined aerobic and resistance training weekly for 16 weeks. Peak oxygen consumption (V̇O2peak) and one repetition maximum (1RM) of leg press, leg extension, and chest press were measured before group assignment, after 16 weeks and at the 1-year follow-up. RESULTS: A significant increase in V̇O2peak (ml min-1 kg-1) (29.7 ± 8.0 vs. 31.3 ± 8.3, p = .009), leg press (kg) (113.0 ± 27.3 vs. 116.7 ± 29.2, p = .047), leg extension (kg) (44.2 ± 10.1 vs. 48.0 ± 10.6, p < .001), and chest press (kg) (24.5 ± 7.5 vs. 26.9 ± 8.2, p = .001) was seen in the PT group from pre- to post-measurement. The PT group maintained the improved aerobic condition and muscle strength 1 year after the training intervention. In the C group, there were no significant differences between pre- and post-measurements, but a significant decrease (28.2 ± 7.5 vs. 27.0 ± 7.3, p = .040) in the V̇O2peak from post to 1-year follow-up measurements. CONCLUSIONS: Combined aerobic and resistance training twice a week in 16 weeks improves V̇O2peak and maximal strength in women treated for gynecological cancer. The training effects were sustained after 1 year in the PT group.
Entities:
Keywords:
Combined aerobic and resistance training; Gynecological cancer; Rehabilitation
Authors: Kerry S Courneya; Kristina H Karvinen; Kristin L Campbell; Robert G Pearcey; George Dundas; Valerie Capstick; Katia S Tonkin Journal: Gynecol Oncol Date: 2005-05 Impact factor: 5.482
Authors: Anne M May; Ellen Van Weert; Irene Korstjens; Josette E H M Hoekstra-Weebers; Cees P Van Der Schans; Maria L Zonderland; Ilse Mesters; Bart Van Den Borne; Wynan D J G Ros Journal: Acta Oncol Date: 2008 Impact factor: 4.089
Authors: Bernardine M Pinto; Carolyn Rabin; George D Papandonatos; Georita M Frierson; Joseph J Trunzo; Bess H Marcus Journal: Support Care Cancer Date: 2008-04-15 Impact factor: 3.603
Authors: Kelcey A Bland; Sarah E Neil-Sztramko; Kendra Zadravec; Mary E Medysky; Jeffrey Kong; Kerri M Winters-Stone; Kristin L Campbell Journal: BMC Cancer Date: 2021-11-05 Impact factor: 4.430